Literature DB >> 1367993

Manipulation of heterogeneous hybridoma cultures for overproduction of monoclonal antibodies.

K L McKinney1, R Dilwith, G Belfort.   

Abstract

In searching for ways to manipulate heterogeneous hybridoma cell cultures (ATCC HB124) to obtain increased production of monoclonal antibodies (IgG2a), we have selected for a higher secreting but slower growing subpopulation using the level of fluorescent surface-associated antibodies and a fluorescence-activated cell sorter. Cell surface fluorescence was found to be correlated with specific antibody secretion rate over the short term but not with intracellular antibody content. Also, the specific secretion rate of a heterogeneous population of hybridoma cells grown in batch culture has been shown to be inversely correlated with an increase in either the initial cell concentration or the medium antibody concentration. Several experiments suggest that an upper limit exists for medium antibody concentration, above which antibody is degraded at the same rate at which it is produced. Should other cell lines behave similarly, strategies for overproduction of monoclonal antibodies suggested herein could be profitably used in industry.

Mesh:

Substances:

Year:  1991        PMID: 1367993     DOI: 10.1021/bp00011a010

Source DB:  PubMed          Journal:  Biotechnol Prog        ISSN: 1520-6033


  10 in total

1.  Specific monoclonal antibody productivity and the cell cycle-comparisons of batch, continuous and perfusion cultures.

Authors:  M al-Rubeai; A N Emery; S Chalder; D C Jan
Journal:  Cytotechnology       Date:  1992       Impact factor: 2.058

2.  Hybridoma growth and productivity: effects of conditioned medium and of inoculum size.

Authors:  R L Dutton; J M Scharer; M Moo-Young
Journal:  Cytotechnology       Date:  1999-01       Impact factor: 2.058

3.  The gel microdrop secretion assay: Identification of a low productivity subpopulation arising during the production of human antibody in CHO cells.

Authors:  L Hammill; J Welles; G R Carson
Journal:  Cytotechnology       Date:  2000-10       Impact factor: 2.058

4.  Techniques for dual staining of DNA and intracellular immunoglobulins in murine hybridoma cells: applications to cell-cycle analysis of hyperosmotic cultures.

Authors:  Kathleen M McNeeley; Zhe Sun; Susan T Sharfstein
Journal:  Cytotechnology       Date:  2005-06       Impact factor: 2.058

5.  Media replenishment: a tool for the analysis of high-cell density perfusion systems.

Authors:  M D Mahadevan; J A Klimkowsky; Y M Deo
Journal:  Cytotechnology       Date:  1994       Impact factor: 2.058

6.  Enhanced specific antibody productivity of calcium alginate-entrapped hybridoma is cell line-specific.

Authors:  G M Lee; S J Kim; B O Palsson
Journal:  Cytotechnology       Date:  1994       Impact factor: 2.058

7.  Engineered cell surface expression of membrane immunoglobulin as a means to identify monoclonal antibody-secreting hybridomas.

Authors:  Paul W Price; Elizabeth C McKinney; Youliang Wang; Loren E Sasser; Muthugapatti K Kandasamy; Linda Matsuuchi; Christine Milcarek; Roger B Deal; Deborah G Culver; Richard B Meagher
Journal:  J Immunol Methods       Date:  2009-01-31       Impact factor: 2.303

8.  Applications of cell sorting in biotechnology.

Authors:  Diethard Mattanovich; Nicole Borth
Journal:  Microb Cell Fact       Date:  2006-03-21       Impact factor: 5.328

9.  A novel selection strategy for antibody producing hybridoma cells based on a new transgenic fusion cell line.

Authors:  Martin Listek; Anja Hönow; Manfred Gossen; Katja Hanack
Journal:  Sci Rep       Date:  2020-02-03       Impact factor: 4.379

10.  SPLICELECT™: an adaptable cell surface display technology based on alternative splicing allowing the qualitative and quantitative prediction of secreted product at a single-cell level.

Authors:  Christel Aebischer-Gumy; Pierre Moretti; Romain Ollier; Christelle Ries Fecourt; François Rousseau; Martin Bertschinger
Journal:  MAbs       Date:  2020 Jan-Dec       Impact factor: 5.857

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.